Treatment resources
Resources to aid in prescribing and treating patients with ZOLGENSMA.
Novartis Patient Support™ Start Form
The Novartis Patient Support Start Form is required for all patients who are prescribed ZOLGENSMA. This completed form must be submitted by your office.
Novartis Patient Support Patient Authorization and Additional Consents Form
The Novartis Patient Support Patient Authorization and Additional Consents Form can be sent for all patients who are prescribed ZOLGENSMA to authorize engagement and the support offerings provided by Novartis Patient Support.
Prior Authorization Criteria Guide
A simple guide to anticipated prior authorization criteria for ZOLGENSMA.
Letter of Medical Necessity Guide
Suggestions for key elements to include when writing a letter of medical necessity in support of ZOLGENSMA.
Sample Letter of Medical Necessity
A sample letter of medical necessity for ZOLGENSMA that may be used for reference.
Letter of Appeals Guide
Suggestions on how to navigate the appeals process for ZOLGENSMA.
Spanish Novartis Patient Support Patient Authorization and Additional Consents Form
A Spanish language Patient Authorization and Additional Consents Form for families who are better served by Spanish resources.
Electronic Health Record Build Kit
A helpful guide to Epic SmartSets, which can help your office manage complex therapies by facilitating processes for orders, prescriptions, labs, patient information, follow-up care notes, and subsequent visits.
ZOLGENSMA Treatment Guide
A guide to storing, handling, and preparing ZOLGENSMA for infusion. The guide also covers pre- and posttreatment corticosteroid and monitoring requirements.
Clinical Reprint List
Summary of clinical publications that may be referenced to help support access for ZOLGENSMA.
Product Ordering Pathways
This guide outlines product support and the ordering process for ZOLGENSMA through the Novartis Limited Distribution Network.
The Novartis Laboratory Testing Program can assist with pre-infusion lab testing including genetic testing/confirmation and AAV9 antibodies. For more information, please contact your Novartis Regional Account Associate Director or call Novartis Patient Support at 1-855-441-4363.
Refer patients for treatment
To locate a treatment center that can administer ZOLGENSMA:
Contact CureSMA email [email protected] ↗
or
Contact the Muscular Dystrophy Association (MDA) Resource Center at 1-833-ASK-MDA1 or email [email protected] ↗
Caregiver resources
Resources to help your patient’s family understand and cope with diagnosis, treatment, and living with SMA.
Explaining SMA and ZOLGENSMA to Others
Prenatal SMA Diagnosis Checklist
A Caregiver’s Guide To ZOLGENSMA
A Step-By-Step Guide To One-Time ZOLGENSMA Treatment
Reimbursement resources
Resources to help you and your practice manage insurance and reimbursement.
ZOLGENSMA Prior Authorization and Appeals Guide
A helpful guide that outlines best practices and key steps in acquiring insurance approval for your patients prescribed ZOLGENSMA.
ZOLGENSMA HCP Coding and Billing Guide
This guide provides necessary information and assists you in obtaining insurance reimbursement for ZOLGENSMA.